A22 Instructional Session: Controversies of prostate cancer screening and active surveillance for low risk prostate cancer – the impact for man and relatives

Abstract

s and learning outcomes / European Journal of Oncology Nursing 14S1 (2010) S1–S62 S9 Instructional Session: Prostate cancer – the impact for man and relatives A22 Instructional Session: Controversies of prostate cancer screening and active surveillance for low risk prostate cancer – the impact for man and relatives E. van Muilekom [Coordinator], R.C.N. van den Bergh [Expert], L. Drudge-Coates [Expert]. Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Diakonessenhuis, Utrecht, The Netherlands; King’s College Hospital NHS Trust, Department of Urology, London, United Kingdom Erik van Muilekom: Introduction in prostate cancer, new developments and trends prostate cancer treatment and coping of man and their relatives Dr. Roderick van den Bergh: Controversies of prostate cancer screening and active surveillance, the impact for man and relatives During this session, the following subjects will be covered: • The rationale of screening for prostate cancer. • Update of the results of the most important randomised studies on the impact of screening for prostate cancer on a population level. • The impact of screening on the quality of life • The rationale behind the strategy of active surveillance for low risk prostate cancer • The impact of active surveillance on the quality of life • Considerations for daily urologic practice regarding screening and active surveillance Session objectives: After attending this session, participants will be able to: • Explain the pros and cons of screening for prostate cancer • Compare the strategy of active surveillance with more radical treatments such as radical prostatectomy or radiation therapy. • Point out the different aspects of screening and active surveillance that influence the quality of life • Apply knowledge in daily urologic practice